Area of research
Immunology · Infectious Diseases
Research interest
Research interests include Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Tuberculosis Research and Epidemiology, and Monoclonal and Polyclonal Antibodies Research.
Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression
Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression.
Chemoprevention of Head and Neck Cancer: A Review of Current Approaches and Future Perspectives.
Tumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth, and Lung Metastasis in a Triple-Negative Breast Cancer Model.
Tumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth and Lung Metastasis in a Triple Negative Breast Cancer Model
Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice.
The magic of small-molecule drugs during <i>ex vivo</i> expansion in adoptive cell therapy.
Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses.
Influenza virus-like particle-based hybrid vaccine containing RBD induces immunity against influenza and SARS-CoV-2 viruses
Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy
Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy.
Expression of tdTomato and luciferase in a murine lung cancer alters the growth and immune microenvironment of the tumor.
Dendritic Cells Pulsed with Cytokine-Adjuvanted Tumor Membrane Vesicles Inhibit Tumor Growth in HER2-Positive and Triple Negative Breast Cancer Models.
Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancer
Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancer.
Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer
Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer
Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer.
Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer.
Antibody Effector Functions Mediated by Fcγ-Receptors Are Compromised during Persistent Viral Infection
Influenza virus‐like particles engineered by protein transfer with tumor‐associated antigens induces protective antitumor immunity
Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growth
Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses
Allogeneic tumor cell vaccines
Differential Role of Lipocalin 2 During Immune Complex–Mediated Acute and Chronic Inflammation in Mice
Formulation and evaluation of oral microparticulate ovarian cancer vaccines